Mates Sharon

Mates Sharon is listed in filings as Chairman and CEO at Intra-Cellular Therapies Inc. (ITCI). This profile follows SEC Form 4 activity through Jan 26, 2026, including sale activity. Recent filings connect the profile to Intra-Cellular Therapies Inc. (ITCI) (ITCI) and Benitec Biopharma Inc. (BNTC). The current snapshot covers public activity from Aug 23, 2024 to Jan 26, 2026. Reported amounts are shown as $2.1M to $148.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.